Retinoic acid is a morphogenetic signaling molecule derived from vitamin A and involved in vertebrate development. Two groups of receptors, retinoic acid receptors and retinoid X receptors (RXRs), have been identified. All-trans-retinoic acid is the high-affmity ligand for retinoic acid receptors, and 9-cis-retinoic acid additionally binds RXRs with high affinity. Here we report that although retinoic acid has little inhibitory effect on activation-induced T-cell proliferation, it specifically prevents activation-induced apoptosis of T-celi hybridomas and antigen-specific deletion of immature CD4+CD8+ thymocytes from ac4 T-cell receptor transgenic mice. 9-cis-Retinoic acid was 410-fold more potent than all-trans-retinoic acid, suggesting that RXRs participate in this process. Thus, although 9-cis-retinoic acid has little immunosuppressive activity, it is a potent negative regulator of activation-induced T-cell apoptosis, raising the possibility that RXRs may take part in regulating T-cell development.
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Retinoids are a group of natural and synthetic vitamin A (retinol) derivatives that modulate the growth and differentiation of many different cells in vivo and in vitro (1, 2) . Many effects of vitamin A are mediated by retinoic acid (RA), and several lines of evidence have shown that RA is a necessary morphogenetic signaling molecule that is produced in local tissues during vertebrate development (3, 4) . RA also has a profound influence on immune cells and immunological responses (5) . Similar to steroid/thyroid hormones, RA binds to intracellular receptors that in turn bind specific responsive elements (RAREs) and regulate gene transcription (6) (7) (8) . Two families of retinoid receptors, RA receptors (RARs) and retinoic X receptors (RXRs), have been identified (9) (10) (11) . All-trans-RA binds RARs with high affinity, and its 9-cis stereoisomer is a high-affinity ligand for both RARs and RXRs (12, 13) . RXRs can form homodimers in the presence of 9-cis-RA (14) or can heterodimerize with RARs. Such heterodimers bind and trans-activate responsive elements much better than RAR or RXR homodimers (15) (16) (17) . Although in transient transfection assays RA-responsive genes can usually be regulated by both RARs or RXRs, there are RAREs that have been found to respond to all-trans-RA much better when the responsive elements are cotransfected with RXRs rather than RARs. Studies on one such RARE, from the CRABPII gene, found that although the binding of RAR-RXR heterodimers can mediate transactivation, 9-cis-RA is more effective than all-trans-RA at stimulating a response (18) . It is not yet clear how these molecular interactions are related to the physiological and pharmacological effects of RA.
Activation of T-cell hybridomas and thymocytes via the T-cell antigen receptor (TCR) induces programed cell death (PCD), which is thought to be the mechanism of thymocyte The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
negative selection (19) (20) (21) (19) .
RESULTS
RA Prevents Activation-Induced T-Cell Hybridoma Death. To determine whether RA could influence activation-induced T-cell PCD, all-trans-RA was added to cultures of the 2B4.11 T-cell hybridoma in the presence or absence of an activating stimulus. All-trans-RA by itself had no effect on T-cell viability as assessed by either specific fragmentation of DNA (Fig. 1A) or release of 51Cr (data not shown). Immobilized anti-CD3 antibodies alone caused -'50% specific DNA fragmentation in the T-hybridoma cells. However, activationdependent PCD was prevented by all-trans-RA in a dosedependent fashion, almost complete inhibition being achieved at 10 AM. Identical results were obtained using release of 51Cr as a measure of cell death (data not shown).
9-cis-RA Is More Potent Than All-trans-RA in Preventing PCD. Studies using receptor and reporter gene cotransfection have shown that although all-trans-RA and 9-cis-RA are equipotent for stimulation of RARs, 9-cis-RA is 10-to 30-fold better than all-trans-RA at activating RXRs (11, 13) . To assess which type of RA mediates inhibition of PCD, we compared the potency of retinol, all-trans-RA, and 9-cis-RA in the DNA fragmentation assay. None of these reagents induced PCD by themselves. 9-cis-RA was 10-fold more potent than all-trans-RA at preventing anti-TCR-mediated PCD in three experiments, one of which is shown in Fig. 1B . Retinol itself had only a small effect on this process and then only at the highest concentration (perhaps due to the conversion of retinol to 9-cis-RA by the cells). 13-cis-RA was also 10-fold less potent than 9-cis-RA in preventing 2B4.11 PCD (data not shown). This hierarchy is typical for phenomena mediated by RXRs (11, 13). 9-cis-RA also blocked DNA fragmentation caused by activation with antigen (pigeon cytochrome c) or the combination of phorbol ester plus a Ca2+ ionophore, ionomycin (data not shown). To determine whether 9-cis-RA could block PCD caused by a nonactivating stimulus, the synthetic glucocorticoid dexamethasone (Dex) was used (Fig. 1C) . As described (22), overnight treatment with Dex caused substantial DNA fragmentation in 2B4.11 cells in a dose-dependent manner. Unlike activation via the TCR, however, addition of 1 ,uM 9-cis-RA did not prevent Dex-induced PCD.
Effects of RA on Other Measures of T-Cell Activation. Activation-induced T-cell hybridoma growth inhibition is largely the consequence of a G1/S-phase cell-cycle block (26). This response is distinct from activation-induced PCD as judged by kinetics (growth inhibition occurs within 1 hr and PCD is first detected at 4-6 hr) and by the observations that PCD but not growth inhibition is prevented by removing Ca2+ from the medium and that cyclosporin A prevents PCD but not the cell-cycle block (31). To determine whether 9-cis-RA globally prevents T-cell hybridoma activation, proliferation of 2B4.11 cells activated with anti-CD3 antibodies in the presence or absence of 9-cis-RA was measured. Unlike its effect on PCD, 9-cis-RA had little effect on anti-TCRinduced growth inhibition (Fig. 2) . IL-2 production by activated 2B4.11 cells was also tested and was consistently found to be partially inhibited (typically 'z50%) by all-trans-RA and 9-cis-RA (data not shown). To determine whether RA is immunosuppressive for normal cells, splenocytes were stimulated in vitro with anti-CD3 antibodies in the presence of various amounts of all-trans-or 9-cis-RA (Fig. 3) . Alltrans-RA had virtually no effect on T-cell proliferation, and 9-cis-RA had only a modest inhibitory effect and then only at lower levels of anti-CD3 stimulation. The supernatant from these wells contained IL-2 (10-15 units/ml); no inhibition of IL-2 production was detected at any concentration of either RA stereoisomer (data not shown). Thus, RA has only a small inhibitory effect on activation of normal T cells.
RA Prevents Antigen-Specific Deletion ofThymocytes. TCRmediated PCD occurs in thymocytes and is thought to be the major mechanism for eliminating cells bearing TCRs with high affinity for self antigens during T-cell ontogeny (negative selection) (21, 32) . Experiments were performed to determine whether the effects of RA on TCR-mediated PCD could be extended to the process of negative selection. Swat et aL (30) have shown that culture of thymocytes from antigen-specific thymocytes; these CD410CD8l0 cells were shown to be undergoing PCD (30). We performed experiments in which thymocytes from female TCR a(3 transgenic mice, for which >90%o of the CD4+CD8+ cells express a TCR that recognizes the male-specific H-Y antigen, were cultured on a monolayer of either female or male thymic APCs. After 36 hr, most of the CD4+CD8+ cells from female thymocytes cultured with female APCs expressed normal levels of CD4 and CD8, although a small number manifested the CD4l0CD8l0 phenotype of dying cells (Fig. 4A) (30) . Culture of thymocytes from female mice with male thymic APCs (H-Y+) resulted in a loss of two-thirds of the CD4+CD8+ cells, with a concomitant increase in the CD4IOCD8I0 cells undergoing PCD (Fig. 4B) . Culture with 0.1 ,uM all-trans-RA resulted in partial recovery of CD4+CD8+ cells, and 1 uM all-trans-RA completely blocked antigen-specific deletion (Fig. 4 C and E) . 9-cis-RA (10 nM) also caused partial recovery of normal CD4+CD8+ cells (m40% reversal of deletion) and at 0.1 ,uM was as effective as 1 ,uM all-trans-RA (Fig. 4 D and F) . Further increases in all-trans-RA or 9-cis-RA concentrations did not result in further increases in the number of CD4+CD8+ cells (data not shown). The 10-fold difference in potency between 9-cis-RA and all-trans-RA suggests that activation of RXRs is a potent means of inhibiting activation-induced negative selection. As originally described in this system (30), H-Yspecific female thymocytes cultured with male APCs exhibited DNA fragmentation; this was also prevented by culture with RA (data not shown). It is possible that RA prevented antigen-specific thymocyte deletion by downregulating expression of the TCR's ligand (H-Y/H-2Db) on the thymic APCs. To test this, male and female APCs were cultured with or without 9-cis-RA for 36 hr and used as targets for an H-Y/H-2Db-specific cytotoxic T-lymphocyte clone (Fig. 4G ). 9-cis-RA did not inhibit antigen-specific T-cell lysis of these APCs, indicating that it does not affect expression of H-Y/H-2Db.
DISCUSSION
RARs and RXRs have overlapping but distinct functions and are responsible for the activity of RA. RXRs can form homodimers in the presence of 9-cis-RA and bind to target gene response elements (14) . In addition, RXRs can form heterodimers with RARs, and the resultant dimers bind response elements at higher affinities than either RAR or ._ .$. RXR homodimers (33). RXRs can also heterodimerize with nuclear receptors, such as those for thyroid hormone, vitamin D3, and others (15) (16) (17) 34) . Although many RAresponsive genes can be regulated both by RARs and RXRs (8) , there may be genes for which expression is regulated predominantly by RXRs (35, 36). It is not yet clear how those molecular interactions relate to the physiologic and pharmacologic effects of retinoids, but it is presumably by regulation of gene transcription that 9-cis-RA exerts its effects on PCD.
As these studies were being completed, another group (37) reported that all-trans-RA prevented activation-induced T-cell hybridoma death and thymocyte death in response to the combination of anti-TCR plus anti-lymphocyte functionassociated antigen antibodies. In addition to these observations, the present work demonstrates that 9-cis-RA is much more potent than all-trans-RA, strongly implicating the RXR in this phenomenon, and that 9-cis-RA prevents antigendriven deletion in immature thymocytes. Previous data on the effects of 9-cis-RA have dealt with its effects on DNA binding and transcriptional regulation of certain genes (12) (13) (14) 38 ). To our knowledge, the data in the present report are the first to demonstrate a specific effect of 9-cis-RA on a physiologic immune function. It is of interest that RXRs can heterodimerize with vitamin D3 receptor in vitro (33) and that RXRs are necessary cofactors for vitamin D3 receptor binding to its response element (39). It may be pertinent that 1,25-dihydroxyvitamin D3 also blocks activation-induced PCD in 2B4.11 cells (unpublished observation), although the significance of this phenomenon and a possible role for the RXR need further investigation.
Vitamin A deficiency has been associated with many immune function abnormalities (2) , some of which may be due to inappropriate and/or deleterious lymphocyte apoptosis. The results with the H-Y-specific TCR transgenic mice indicate that RA can prevent TCR-mediated thymocyte deletion. Would lack of endogenous RA result in enhanced negative selection? In preliminary studies, we have analyzed the effect of RA depletion on thymocyte development. The RA-deficient animals had markedly reduced thymocyte numbers, largely due to loss of CD4+CD8+ cells, with little change in the number of CD4-CD8-cells (unpublished observation). It is an intriguing speculation that in the absence of RA even low-affinity TCR-self antigen interactions are sufficient to result in CD4+CD8+ cell PCD. Although these observations are consistent with the notion that RA might be involved in T-cell selection, it is also possible that the effect of RA depletion is indirect, affecting thymocyte development by altering, for example, the levels of other biologically active molecules such as glucocorticoids. Studies on the in vivo effects of RA in TCR transgenic animals may help elucidate what role this retinoid might play in development of the T-cell antigen-specific repertoire.
